Compare ARCI & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARCI | NAGE |
|---|---|---|
| Founded | 2025 | 1999 |
| Country | United States | United States |
| Employees | N/A | 117 |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 349.8M | 290.7M |
| IPO Year | 2026 | N/A |
| Metric | ARCI | NAGE |
|---|---|---|
| Price | $9.96 | $3.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 40.3K | ★ 939.6K |
| Earning Date | N/A | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $16.51 |
| Revenue Next Year | N/A | $14.58 |
| P/E Ratio | ★ N/A | $21.29 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.83 | $3.57 |
| 52 Week High | $10.06 | $14.66 |
| Indicator | ARCI | NAGE |
|---|---|---|
| Relative Strength Index (RSI) | 65.88 | 32.49 |
| Support Level | $9.90 | N/A |
| Resistance Level | $10.06 | $5.22 |
| Average True Range (ATR) | 0.01 | 0.22 |
| MACD | 0.00 | -0.05 |
| Stochastic Oscillator | 100.00 | 7.31 |
Archimedes Tech SPAC Partners III Co is a blank check company.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.